We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.43B
AUM Growth
+$75.3M
Cap. Flow
-$42M
Cap. Flow %
-1.22%
Top 10 Hldgs %
13.83%
Holding
1,352
New
131
Increased
487
Reduced
534
Closed
83

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$9.73M
2
MSFT icon
Microsoft
MSFT
+$6.54M
3
LMT icon
Lockheed Martin
LMT
+$5.54M
4
DD icon
DuPont de Nemours
DD
+$5.19M
5
AAPL icon
Apple
AAPL
+$4.57M

Sector Composition

Rank Sector Weight
1 Healthcare 14.45%
2 Technology 10.24%
3 Financials 10.23%
4 Industrials 9%
5 Consumer Discretionary 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALU icon
876
Kaiser Aluminum
KALU
$2.67B
$423K 0.01%
4,890
+253
+5% +$21.7K
BKNG icon
877
Booking.com
BKNG
$138B
$422K 0.01%
7,175
-500
-7% -$27.9K
MLNX
878
DELISTED
Mellanox Technologies, Ltd.
MLNX
$422K 0.01%
+9,750
New +$431K
TSLF
879
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$420K 0.01%
25,500
+2,000
+9% +$32.6K
ALK icon
880
Alaska Air
ALK
$5.15B
$419K 0.01%
+6,370
New +$419K
WGL
881
DELISTED
Wgl Holdings
WGL
$418K 0.01%
6,662
-500
-7% -$33.3K
OUSA icon
882
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$737M
$413K 0.01%
15,061
+2,652
+21% +$73.8K
DLN icon
883
WisdomTree US LargeCap Dividend Fund
DLN
$6.24B
$410K 0.01%
10,662
+500
+5% +$19.3K
EFG icon
884
iShares MSCI EAFE Growth ETF
EFG
$16.3B
$410K 0.01%
5,991
IEP icon
885
Icahn Enterprises
IEP
$5.17B
$407K 0.01%
8,050
+97
+1% +$5.12K
VVR icon
886
Invesco Senior Income Trust
VVR
$456M
$406K 0.01%
93,810
+1,542
+2% +$6.64K
SRPT icon
887
Sarepta Therapeutics
SRPT
$1.66B
$405K 0.01%
6,602
-13,611
-67% -$411K
FDUS icon
888
Fidus Investment
FDUS
$737M
$402K 0.01%
25,513
-241
-0.9% -$3.81K
COR
889
DELISTED
Coresite Realty Corporation
COR
$402K 0.01%
+5,433
New +$441K
NAD icon
890
Nuveen Quality Municipal Income Fund
NAD
$2.71B
$401K 0.01%
+26,611
New +$413K
BRKL
891
DELISTED
Brookline Bancorp
BRKL
$400K 0.01%
32,800
-36,939
-53% -$429K
SCD
892
LMP Capital and Income Fund
SCD
$353M
$398K 0.01%
29,168
+5,143
+21% +$70.1K
MRSH
893
Marsh
MRSH
$86.3B
$397K 0.01%
5,905
-111
-2% -$7.43K
CPHD
894
DELISTED
Cepheid Inc
CPHD
$396K 0.01%
7,507
-3,812
-34% -$152K
FSD
895
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$394K 0.01%
25,273
+1,512
+6% +$23.3K
TPST icon
896
Tempest Therapeutics
TPST
$14.8M
$393K 0.01%
19
+1
+6% +$18.1K
GARS
897
DELISTED
Garrison Capital Inc.
GARS
$393K 0.01%
38,832
+962
+3% +$10K
IYJ icon
898
iShares US Industrials ETF
IYJ
$1.98B
$392K 0.01%
6,850
+454
+7% +$25.8K
QEP
899
DELISTED
QEP RESOURCES, INC.
QEP
$391K 0.01%
20,000
DNR
900
DELISTED
Denbury Resources, Inc.
DNR
$391K 0.01%
121,049
+6,000
+5% +$18.4K

Similar funds

Oppenheimer & Co's Q3 2016 Portfolio in Review

As of Q3 2016, Oppenheimer & Co held 1,352 positions worth $3.43B, up 2.2% from $3.35B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q3 2016 filing shows 131 new, 487 increased, 534 reduced and 83 closed positions. Its largest new stake was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M. The largest sale was GE Aerospace, an estimated $9.73M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

  • Oppenheimer & Co's largest Q3 2016 buy was Brookfield Infrastructure Partners: 168,877 shares worth $3.48M.
  • Oppenheimer & Co added most to Bristol-Myers Squibb in Q3 2016, an estimated $6.72M increase.
  • Oppenheimer & Co's biggest Q3 2016 reduction was GE Aerospace, cutting an estimated $9.73M.
  • Oppenheimer & Co fully exited Agrium in Q3 2016, selling an estimated $3.32M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.43B portfolio in Q3 2016.
  • Oppenheimer & Co opened 131 new positions and closed 83 in Q3 2016.
  • Oppenheimer & Co's portfolio value rose 2.2% quarter-over-quarter to $3.43B.

Based on Oppenheimer & Co's 13F filing for Q3 2016, filed 7 Nov 2016.